Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 4.2 EX-4.2
- 10.1 EX-10.1
- 10.2 EX-10.2(A)
- 10.2 EX-10.2(B)
- 10.2 EX-10.2(C)
- 10.4 EX-10.4(A)
- 10.4 EX-10.4(B)
- 10.4 EX-10.4(C)
- 10.4 EX-10.4(D)
- 10.4 EX-10.4(E)
- 10.4 EX-10.4(F)
- 10.5 EX-10.5(A)
- 10.5 EX-10.5(B)
- 10.5 EX-10.5(C)
- 10.5 EX-10.5(D)
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9(A)
- 10.9 EX-10.9(B)
- 10.10 EX-10.10(A)
- 10.10 EX-10.10(B)
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13(A)
- 10.13 EX-10.13(B)
- 10.14 EX-10.14
- 10.15 EX-10.15
- 23.1 EX-23.1
CRVS similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of Corvus Pharmaceuticals, Inc. of our report dated November 6, 2015 relating to the financial statements of Corvus Pharmaceuticals, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
January 4, 2016
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM